Heart failure is a life threatening disorder in worldwide and many papers reported about myocardial regeneration
through surgical method induced by LVAD, cellular cardiomyoplasty (cell injection), tissue cardiomyoplasty (bioengineered
cardiac graft implantation), in situ engineering (scaffold implantation), and LV restrictive devices. Some of these
innovated technologies have been introduced to clinical settings. This review article provides summary about recent basical
and clinical advances about myocardial regeneration induced by bioengineered cardiac tissue.
Keywords: Cells, heart failure, tissue engineering, myocardial regeneration
Rights & PermissionsPrintExport